An experimental vaccine for kidney cancer is off to a promising start. In data from a Phase I trial released this week, the ...
A complainant shared four third-party posts on X (formerly Twitter) and two online articles with the PMCPA to make the case that Moderna had breached the U.K. marketing code. Initially, the PMCPA ...
A Massachusetts biopharma giant is at the center of preparations already underway if bird flu mutates and begins to find ...
Moderna is the only company in its peer group burning cash at an alarming rate. Click here to read more about MRNA stock and ...
The following first ran on CounterPunch at the height of the COVID pandemic in January of 2022. Are anti-vaccine ...
BRITS are being urged to stay at home and mask up when venturing outside after a “worrying” surge in norovirus cases. While ...
Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...
Moderna Inc (NASDAQ:MRNA) shares are trading lower Wednesday after Goldman Sachs downgraded the stock. Here's what you need ...
Goldman Sachs downgraded the vaccine maker to Neutral from Buy and slashed its stock-price target to $51 from $99 Wednesday.
Robert F. Kennedy Jr., the HHS secretary nominee, has said he is not antivaccine, but he has a track record of casting doubt ...
Moderna (MRNA) stock falls as Goldman Sachs downgrades the COVID-19 vaccine maker to Neutral from Buy, citing a lack of ...
Caroline Kennedy on Tuesday warned that her cousin Robert F. Kennedy Jr. is a “predator” ahead of his high-profile ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results